LuciPona 15 mg is an anticancer medicine used in the
treatment of chronic myeloid leukemia and other resistant blood cancers. It is
particularly effective in patients with specific genetic mutations. This
medicine is widely used across the United Kingdom, United States, Australia,
Singapore and Philippines in advanced cancer care. LuciPona helps control
disease progression and improves patient outcomes when taken under specialist
supervision.
Active Ingredient
Ponatinib is a tyrosine kinase inhibitor that blocks abnormal proteins
responsible for cancer cell growth. It targets specific mutations that make
other treatments less effective.
Uses of LuciPona 15 mg
• Treatment of chronic myeloid leukemia
• Management of resistant leukemia cases
• Relief from cancer related symptoms
• Support for targeted cancer therapy
How LuciPona 15 mg Works
Ponatinib inhibits tyrosine kinase enzymes involved in cancer cell signaling.
This prevents abnormal cell growth and induces cancer cell death thereby
controlling disease progression.
How to Use LuciPona 15 mg
- Take
once daily as prescribed
- Swallow
whole with water
- Follow
medical instructions strictly
Possible Side Effects
• Hypertension
• Fatigue
• Abdominal pain
• Rash
Precautions
• Monitor blood pressure regularly
• Inform doctor about heart conditions
• Avoid during pregnancy
Safety Information
Use under strict medical supervision. Regular monitoring is required to manage
potential side effects and ensure treatment safety.
• Store below 30°C
• Keep in original packaging
• Keep away from children